Parkinson’s is often framed around dopamine, but this clip looks deeper at what may be happening inside the cell. Oxidative stress, inflammation, chronic infection, and environmental toxins can interfere with key thiamine-dependent enzymes involved in energy production, including pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase. That raises a bigger question about whether impaired B1-dependent metabolism is part of the disease process itself.

A normal blood or urine test may still miss a thiamine problem that is localized to a specific part of the brain. This clip explains how researchers have reported region-specific or functional B1 abnormalities in Parkinson’s, Alzheimer’s, Huntington’s, and other neurodegenerative conditions, including problems with transporting thiamine into vulnerable brain tissue. It also looks at animal research using high-dose B1 with biotin, and why these findings have led to further human investigation.

Some Parkinson’s patients show normal thiamine levels on standard blood tests, yet case reports have described substantial improvement after high-dose B1. This clip explores why thiamine responsiveness may not always look like a classic deficiency, and why normal blood or red-cell levels may not tell the full story about how B1 is functioning inside the nervous system.